BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32303635)

  • 21. Unique Transcriptional Architecture in Airway Epithelial Cells and Macrophages Shapes Distinct Responses following Influenza Virus Infection
    Ma JZ; Ng WC; Zappia L; Gearing LJ; Olshansky M; Pham K; Cheong K; Hsu A; Turner SJ; Wijburg O; Londrigan SL; Brooks AG; Reading PC
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells.
    Rodriguez-Frandsen A; Martin-Sancho L; Gounder AP; Chang MW; Liu WC; De Jesus PD; von Recum-Knepper J; Dutra MS; Huffmaster NJ; Chavarria M; Mena I; Riva L; Nguyen CB; Dobariya S; Herbert KM; Benner C; Albrecht RA; García-Sastre A; Chanda SK
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1.
    Zmora P; Hoffmann M; Kollmus H; Moldenhauer AS; Danov O; Braun A; Winkler M; Schughart K; Pöhlmann S
    J Biol Chem; 2018 Sep; 293(36):13863-13873. PubMed ID: 29976755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene editing of pigs to control influenza A virus infections.
    Kwon T; Artiaga BL; McDowell CD; Whitworth KM; Wells KD; Prather RS; Delhon G; Cigan M; White SN; Retallick J; Gaudreault NN; Morozov I; Richt JA
    bioRxiv; 2024 Jan; ():. PubMed ID: 38293027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of c-jun N-terminal kinase upon influenza A virus (IAV) infection is independent of pathogen-related receptors but dependent on amino acid sequence variations of IAV NS1.
    Nacken W; Anhlan D; Hrincius ER; Mostafa A; Wolff T; Sadewasser A; Pleschka S; Ehrhardt C; Ludwig S
    J Virol; 2014 Aug; 88(16):8843-52. PubMed ID: 24872593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A peptide-based approach to evaluate the adaptability of influenza A virus to humans based on its hemagglutinin proteolytic cleavage site.
    Straus MR; Whittaker GR
    PLoS One; 2017; 12(3):e0174827. PubMed ID: 28358853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zoonotic Risk, Pathogenesis, and Transmission of Avian-Origin H3N2 Canine Influenza Virus.
    Sun H; Blackmon S; Yang G; Waters K; Li T; Tangwangvivat R; Xu Y; Shyu D; Wen F; Cooley J; Senter L; Lin X; Jarman R; Hanson L; Webby R; Wan XF
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Finding proteases that make cells go viral.
    Aguilar HC; Buchholz DW
    J Biol Chem; 2020 Aug; 295(33):11408-11409. PubMed ID: 32817125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system.
    Patel U; Gingerich A; Widman L; Sarr D; Tripp RA; Rada B
    PLoS One; 2018; 13(7):e0199167. PubMed ID: 30044776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-29a is a negative regulator of influenza virus infection through targeting of the frizzled 5 receptor.
    Yang X; Liang Y; Bamunuarachchi G; Xu Y; Vaddadi K; Pushparaj S; Xu D; Zhu Z; Blaha R; Huang C; Liu L
    Arch Virol; 2021 Feb; 166(2):363-373. PubMed ID: 33206218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
    Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host envelope glycoprotein processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses.
    Kido H; Okumura Y; Takahashi E; Pan HY; Wang S; Chida J; Le TQ; Yano M
    J Mol Genet Med; 2008 Nov; 3(1):167-75. PubMed ID: 19565019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H5N1 Influenza A Virus PB1-F2 Relieves HAX-1-Mediated Restriction of Avian Virus Polymerase PA in Human Lung Cells.
    Mazel-Sanchez B; Boal-Carvalho I; Silva F; Dijkman R; Schmolke M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts.
    Bertram S; Heurich A; Lavender H; Gierer S; Danisch S; Perin P; Lucas JM; Nelson PS; Pöhlmann S; Soilleux EJ
    PLoS One; 2012; 7(4):e35876. PubMed ID: 22558251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential interferon responses to influenza A and B viruses in primary ferret respiratory epithelial cells.
    Rowe T; Davis W; Wentworth DE; Ross T
    J Virol; 2024 Feb; 98(2):e0149423. PubMed ID: 38294251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Ongoing Influenza A Virus Replication Reveals Different Mechanisms of RIG-I Activation.
    Liu G; Lu Y; Liu Q; Zhou Y
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of MHC Class I Expression by Influenza A and B Viruses.
    Koutsakos M; McWilliam HEG; Aktepe TE; Fritzlar S; Illing PT; Mifsud NA; Purcell AW; Rockman S; Reading PC; Vivian JP; Rossjohn J; Brooks AG; Mackenzie JM; Mintern JD; Villadangos JA; Nguyen THO; Kedzierska K
    Front Immunol; 2019; 10():1158. PubMed ID: 31191533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity.
    Hoffmann M; Hofmann-Winkler H; Smith JC; Krüger N; Arora P; Sørensen LK; Søgaard OS; Hasselstrøm JB; Winkler M; Hempel T; Raich L; Olsson S; Danov O; Jonigk D; Yamazoe T; Yamatsuta K; Mizuno H; Ludwig S; Noé F; Kjolby M; Braun A; Sheltzer JM; Pöhlmann S
    EBioMedicine; 2021 Mar; 65():103255. PubMed ID: 33676899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
    Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Role for PDZ-Binding Motif of Influenza A Virus Nonstructural Protein 1 in Regulation of Host Susceptibility to Postinfluenza Bacterial Superinfections.
    Shepardson K; Larson K; Cho H; Johns LL; Malkoc Z; Stanek K; Wellhman J; Zaiser S; Daggs-Olson J; Moodie T; Klonoski JM; Huber VC; Rynda-Apple A
    Viral Immunol; 2019 Apr; 32(3):131-143. PubMed ID: 30822217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.